Evaluate the Safety and Clinical Activity of HH2853
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fugen Li
Haihe Biopharma Co., Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Jishuitan Hospital
Beijing, Beijing Municipality, China
Recruiting - Sun Yat-Sen University Cancer Hospital
Guangzhou, Guangdong, China
Jundong LiRecruiting - Affiliated Tumor Hospital of Guangxi Medical University
Nanning, Guangxi, China
Weimin XieRecruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Jing ChenRecruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Xianan LiRecruiting - Affiliated Drum Tower Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, China
Recruiting - Liaoning Cancer Hospital&institute
Shenyang, Liaoning, China
Recruiting - Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Recruiting - Linyi Tumor Hospital
Linyi, Shandong, China
Recruiting - Shanghai Sixth People'S Hospital
Shanghai, Shanghai Municipality, China
Recruiting - Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Recruiting - Shanxi Cancer Hospital
Taiyuan, Shanxi, China
Recruiting - West China Hospital of Sichuan University
Chengdu, Sichuan, China
Recruiting - Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, China
Jilong YangShiyong ZhouYun YangRecruiting - Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Haiyan YangRecruiting - Beijing Cancer Hospital
Beijing, China
Recruiting - Sun Yat-Sen University Cancer Hospital
Guangzhou, China
Recruiting
- Mayo Clinic
Phoenix, Arizona, United States
Completed - Mayo Clinic
Jacksonville, Florida, United States
Completed - Mayo Clinic
Rochester, Minnesota, United States
Completed - Next Oncology
San Antonio, Texas, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2020
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2028
- Last update posted
- 30 Jan 2026
- Registered enrollment
- 254
- Registry id
- NCT04390737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.